Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
4.000
0.00 (0.00%)
At close: May 18, 2026, 4:00 PM EDT
3.900
-0.100 (-2.50%)
Pre-market: May 19, 2026, 4:32 AM EDT
TVRD's stock price has decreased by -84.15% in the past year and price targets may not have had time to catch up.
Tvardi Therapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Buy
Price Target
$27.60
Upside
+590.00%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold → Sell Downgrades $4 → $3 | Hold → Sell | Downgrades | $4 → $3 | -25.00% | Apr 20, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +275.00% | Apr 1, 2026 |
| Barclays | Barclays | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | n/a | Apr 1, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | -25.00% | Apr 1, 2026 |
| Raymond James | Raymond James | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 14, 2025 |
| BTIG | BTIG | Strong Buy Maintains $55 → $15 | Strong Buy | Maintains | $55 → $15 | +275.00% | Oct 13, 2025 |
| Barclays | Barclays | Buy Initiates $61 | Buy | Initiates | $61 | +1,425.00% | Oct 13, 2025 |
| Raymond James | Raymond James | Buy Initiates $62 | Buy | Initiates | $62 | +1,450.00% | Jul 14, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $52 | Buy | Initiates | $52 | +1,200.00% | Jul 11, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $78 | Buy | Initiates | $78 | +1,850.00% | Jun 12, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $65 | Buy | Initiates | $65 | +1,525.00% | May 21, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $39 | Strong Buy | Initiates | $39 | +875.00% | Apr 28, 2025 |